These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2073767)

  • 21. Reversible renal insufficiency in multiple myeloma.
    Bernstein SP; Humes HD
    Arch Intern Med; 1982 Nov; 142(12):2083-6. PubMed ID: 7138157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinico-pathological characteristics and outcome in hemolytic-uremic syndrome of adults.
    Matsumae T; Takebayashi S; Naito S
    Clin Nephrol; 1996 Mar; 45(3):153-62. PubMed ID: 8706355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C; Ardiet C; Bret M; Laville M; Fiere D; Tranchand B; Fouque D
    J Nephrol; 2002; 15(6):684-9. PubMed ID: 12495285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis and serum creatinine levels in acute renal failure at the time of nephrology consultation: an observational cohort study.
    Perez-Valdivieso JR; Bes-Rastrollo M; Monedero P; de Irala J; Lavilla FJ
    BMC Nephrol; 2007 Sep; 8():14. PubMed ID: 17894896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successful haemodialysis treatment of acute renal failure in a patient with multiple myeloma (author's transl)].
    Kopsa H; Schmidt P; Zazgornik J; Balcke P; Deutsch E
    Med Klin; 1978 May; 73(18):668-70. PubMed ID: 651757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maintenance hemodialysis in IgD- lambda -type multiple myeloma associated with severe renal failure].
    Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):177-81. PubMed ID: 8139151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass.
    Luckraz H; Gravenor MB; George R; Taylor S; Williams A; Ashraf S; Argano V; Youhana A
    Eur J Cardiothorac Surg; 2005 May; 27(5):906-9. PubMed ID: 15848334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
    Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
    Wehrmann M; Bohle A; Bogenschütz O; Eissele R; Freislederer A; Ohlschlegel C; Schumm G; Batz C; Gärtner HV
    Clin Nephrol; 1989 Feb; 31(2):67-76. PubMed ID: 2920470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High risk acute renal failure.
    Wheeler DC; Feehally J; Walls J
    Q J Med; 1986 Oct; 61(234):977-84. PubMed ID: 3628709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal disease is a prodrome of multiple myeloma: an analysis of 50 patients from eastern India.
    Prakash J; Mandal AK; Vohra R; Wani IA; Hota JK; Raja R; Singh U
    Ren Fail; 2009; 31(4):267-71. PubMed ID: 19462274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystalloid deposits in the kidney.
    Keller LS; Faull RJ; Smith P; Swift J; Bannister KM; Otto S; Peh CA
    Nephrology (Carlton); 2005 Feb; 10(1):81-3. PubMed ID: 15705186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal disease and patient survival in light chain deposition disease.
    Pozzi C; Fogazzi GB; Banfi G; Strom EH; Ponticelli C; Locatelli F
    Clin Nephrol; 1995 May; 43(5):281-7. PubMed ID: 7634543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients.
    Cavo M; Baccarani M; Galieni P; Gobbi M; Tura S
    Nouv Rev Fr Hematol (1978); 1986; 28(3):147-52. PubMed ID: 3748798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study.
    Graziani G; Bordone G; Bellato V; Finazzi S; Angelini C; Badalamenti S;
    J Nephrol; 2006; 19(2):176-82. PubMed ID: 16736416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.
    Rayner HC; Haynes AP; Thompson JR; Russell N; Fletcher J
    Q J Med; 1991 Jun; 79(290):517-25. PubMed ID: 1946932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.